Hyperphosphatemia

Displaying 1 - 2 of 2CSV
Schönherr, H., Ayaz, P., Taylor, A. M., Casaletto, J. B., Touré, B. B., Moustakas, D. T., Hudson, B. M., Valverde, R., Zhao, S., O’Hearn, P. J., Foster, L., Sharon, D. A., Garfinkle, S., Giordanetto, F., Lescarbeau, A., Kurukulasuriya, R., Gerami-Moayed, N., Maglic, D., Bruderek, K., … Bergstrom, D. A. (2024). Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2. Proceedings of the National Academy of Sciences, 121(6). https://doi.org/10.1073/pnas.2317756121
Publication Date
Jadav, P. R., Husain, S. A., Mohan, S., & Crew, R. (2022). Non calcium phosphate binders - Is there any evidence of benefit. Current Opinion in Nephrology & Hypertension, 31(3), 288–296. https://doi.org/10.1097/mnh.0000000000000796
Publication Date